drugset / Trial / NCT00588640

Study of D-Methadone in Patients With Chronic Pain

NCT00588640 ↗

Phase 1/2 Completed 10 enrolled Memorial Sloan Kettering Cancer Center
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine the safest dose of d-methadone that can be given, without causing severe side effects in most patients with chronic pain. Patients are being asked to participate in the Phase I portion of this study.

Timeline

Start
2004-10
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject D-methadone Unknown 40 mg —